Page last updated: 2024-11-07

dextroamphetamine and Developmental Psychomotor Disorders

dextroamphetamine has been researched along with Developmental Psychomotor Disorders in 2 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Research Excerpts

ExcerptRelevanceReference
" This study intended to investigate the effect of an increased intensity of physiotherapy in combination with dexamphetamine the first week after ischemic stroke in patients with an impaired level of consciousness and severe motor dysfunction."2.71Intensive early physiotherapy combined with dexamphetamine treatment in severe stroke: a randomized, controlled pilot study. ( Eksborg, S; Martinsson, L; Wahlgren, NG, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirkpatrick, MG1
Gunderson, EW1
Johanson, CE1
Levin, FR1
Foltin, RW1
Hart, CL1
Martinsson, L1
Eksborg, S1
Wahlgren, NG1

Trials

2 trials available for dextroamphetamine and Developmental Psychomotor Disorders

ArticleYear
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
    Addiction (Abingdon, England), 2012, Volume: 107, Issue:4

    Topics: Administration, Intranasal; Adult; Ambulatory Care; Amphetamine-Related Disorders; Cardiovascular Di

2012
Intensive early physiotherapy combined with dexamphetamine treatment in severe stroke: a randomized, controlled pilot study.
    Cerebrovascular diseases (Basel, Switzerland), 2003, Volume: 16, Issue:4

    Topics: Aged; Aged, 80 and over; Central Nervous System Stimulants; Combined Modality Therapy; Dextroampheta

2003